Neurological Standard: Epilepsy, Seizures & Other Neurologic Conditions

Two Standards Under One Umbrella

Two adjoining paragraphs of 391.41(b) govern the nervous system, and they test different things. 391.41(b)(7) disqualifies a driver with an established medical history or clinical diagnosis of rheumatic, arthritic, orthopedic, muscular, neuromuscular, or vascular disease that interferes with the ability to control and operate a CMV safely — this is the standard that reaches conditions like multiple sclerosis, Parkinson's disease, residual stroke deficits, ALS, and peripheral neuropathy. 391.41(b)(8) is narrower and stricter: no established medical history or clinical diagnosis of epilepsy or any other condition likely to cause loss of consciousness or any loss of ability to control a CMV. This is the seizure standard, and it is one of the few 391.41(b) items with hard, numeric advisory criteria rather than pure ME judgment.

Epilepsy: A Driver on Medication Does Not Qualify

A critical, frequently-missed point: a driver with an epilepsy diagnosis who is currently taking anti-seizure medication does not meet the base standard, no matter how well-controlled the seizures are. Being seizure-free while medicated is not the same as being qualified under 391.41(b)(8) — the standard is written around the underlying diagnosis, not just current seizure activity. Qualification requires meeting one of the pathways below.

Advisory-Criteria Waiting Periods

FMCSA's Medical Advisory Criteria (Appendix A to Part 391) sets out the waiting periods an ME applies directly, without a separate federal application:

The Federal Seizure/Epilepsy Exemption Program

Drivers who remain on antiseizure medication, or who have not yet reached the off-medication waiting period, are not automatically shut out — they may apply through FMCSA's federal seizure/epilepsy exemption program, administered by FMCSA's Medical Programs Division. Applicants must submit neurologist evaluations and documentation of a stable, well-managed seizure history; each application is decided case-by-case rather than against one fixed year count, since a stable medication regimen and a long medically-supervised seizure-free interval both weigh in the applicant's favor. An approved exemption lets FMCSA grant qualification despite the driver not independently meeting the off-medication advisory-criteria waiting period.

Other Neurological Conditions Under (b)(7)

Conditions like multiple sclerosis, Parkinson's disease, ALS, and peripheral neuropathy do not have their own numeric waiting-period table — the ME evaluates the degree of functional impairment: strength, coordination, sensation, reaction time, and cognition, plus the condition's expected rate of progression. A driver recovering from stroke or TIA is assessed for residual motor or cognitive deficit and recurrence risk before being certified. Any single episode of unexplained loss of consciousness is treated as presumptively falling under (b)(8) — disqualifying — until a cause is identified and epilepsy is specifically ruled in or out; the driver cannot be certified on the theory that "it probably wasn't a seizure" without a diagnostic workup establishing that.

Loss of Consciousness Beyond Epilepsy

"Loss of consciousness or any loss of ability to control" under (b)(8) is broader than epilepsy alone — it also captures syncope of unclear origin, transient ischemic attacks, and other episodes that could recur behind the wheel. Because syncope can be cardiac in origin, a driver's unexplained loss-of-consciousness episode often needs a coordinated workup that overlaps with the cardiovascular standard: cardiac monitoring or an echocardiogram to rule out an arrhythmic or structural cause before the episode can be attributed to, or ruled out as, a seizure.

Functional Assessment for Progressive Conditions

For multiple sclerosis, Parkinson's disease, ALS, and peripheral neuropathy, the ME's assessment under (b)(7) is functional rather than diagnostic: gait and balance affecting pedal transitions and cab entry/exit, tremor affecting steering-wheel and control precision, sensory loss affecting the driver's ability to feel pedal pressure or a slipping grip, and any cognitive change affecting hazard recognition and decision-making. Because these conditions can progress, the certification interval should reflect the expected rate of progression — a stable, slowly-progressive case may support the standard interval with specialist follow-up, while a rapidly progressive case warrants a shorter interval or referral before certifying at all. Medication effects matter too: some antiseizure and neurologic medications carry sedating or cognitive side effects that the ME should weigh separately from whether the underlying waiting period has been met.

Documentation and Referral

Because both standards hinge on diagnosis and functional effect rather than a single exam-room test, the ME's job in this section is largely about the history: querying every affirmative answer on the health-history statement about seizures, blackouts, strokes, tremor, weakness, or numbness, and referring to a neurologist whenever the diagnosis, stability, or seizure-free interval cannot be confirmed from the record in front of the ME. When referring, the ME typically requests neurology records establishing the diagnosis type, the most recent seizure date, the current medication regimen (or its discontinuation date), EEG or imaging findings if available, and the specialist's opinion on driving safety — the same documentation-first approach used throughout the diagnostics-and-referral workflow.